Bulldog Investors, LLP - CLARUS THERAPEUTICS HLDNGS I ownership

Back to all holdings Add to watchlist

CLARUS THERAPEUTICS HLDNGS I's ticker is and the CUSIP is 18271L115. A total of 20 filers reported holding CLARUS THERAPEUTICS HLDNGS I in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
Bulldog Investors, LLP ownership history of CLARUS THERAPEUTICS HLDNGS I
ValueSharesWeighting
Q2 2022$1,000
-83.3%
14,011
-67.1%
0.00%
-100.0%
Q1 2022$6,000
-50.0%
42,601
-1.5%
0.00%
-33.3%
Q4 2021$12,000
-63.6%
43,258
-0.8%
0.00%
-66.7%
Q3 2021$33,000–43,590–0.01%–
 Download
Other shareholders

There were no reported owners of CLARUS THERAPEUTICS HLDNGS I in Q2 2022.

NameSharesValueWeighting ↓
View complete list of CLARUS THERAPEUTICS HLDNGS I shareholders